Microbiome JPM 2026: Corsera’s Rena Denoncourt and Meredith Kaya on Annual RNAi for Heart HealthBy adminJanuary 26, 20260 In late 2024, Corsera Health came up with a big, hairy, audacious goal thesis: cardiovascular disease, the world’s leading…
Microbiome JPM 2026: Novo Nordisk’s Jacob Peterson on the Future of Obesity TherapeuticsBy adminJanuary 24, 20260 Novo Nordisk is doubling down on obesity and diabetes. Speaking with Inside Precision Medicine at the 2026 J.P. Morgan Healthcare…
Microbiome JPM 2026: Genoa Ventures’ Jenny Rooke on Next-Gen Clinical Assessment ToolsBy adminJanuary 23, 20260 Jenny Rooke, PhD, started the investment company Genoa Ventures out of frustration. As a geneticist, she saw firsthand how the…
Microbiome JPM 2026: Dyno Tx’s AI-Evolved AAVs Rewrite Rules of Brain Gene Therapy DeliveryBy adminJanuary 12, 20260 Credit: Dusan Stankovic / Getty Images / DigitalVision Vectors Eric Kelsic, PhD, has spent years thinking about how to target…
